Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C8 | P10632 | 6/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14217296 | 0.91 | KCNH2 (0.68) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL142336 | 0.91 | KCNH2 (0.68) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL9919844 | 0.89 | CYP2C8 (0.66) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL18752213 | 0.87 | CYP2C8 (0.55) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL12447856 | 0.84 | KCNH2 (0.60) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL10242360 | 0.83 | CYP2C8 (0.58) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL1919345 | 0.83 | CYP2C8 (0.58) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL18751750 | 0.82 | CYP2C8 (0.52) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL1919338 | 0.82 | CYP2C8 (0.57) | CYP2C8KCNH2CYP3A4NR1I2 | |
| SCHEMBL2141860 | 0.81 | CYP2C8 (0.84) | CYP2C8KCNH2CYP3A4NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2545051-B1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2017-04-19 | — | — | EP | disclosed |